1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
64EC492769996784385256DDA0056B4F0
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/best-practices-in-speaker-training-and-development-driving-pharmaceutical-brand-growth
18
19EditDocument&Seq=1
2034.229.194.198
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR



Access. Intelligence. Excellence

Advanced Search


» Products & Services » »

Best Practices in Speaker Training and Development: Driving Pharmaceutical Brand Growth

ID: SM-158

Features:

5 Info Graphics

7 Data Graphics

8 Metrics

16 Narratives

35 Best Practices

Pages: 70

Published: Pre-2013

Delivery Format: Shipped

 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.


Buy Now

 

919-403-0251
Schedule a Meeting

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
This report focuses primarily on speaker training and development, a crucial link of the entire speaker management process. Report owners will learn how leading companies design an effective, competitive training program, effectively identify potential speakers and optimize the use of speakers and structure key stakeholder groups to have the greatest impact on speaker training. Learn how top pharmaceutical and biotech companies ensure the physicians that speak on their behalf are top-notch communicators of product benefits. This study highlights speaker training program logistics as well as the infrastructures companies have in place to develop physicians into effective speakers. To stay ahead of the competition, companies must recruit influential physicians and develop them into strong brand advocates.  Forward-looking companies build organizational capabilities that enable them to systematically manage speakers as valuable assets. 

Industries Profiled:
Biotech; Pharmaceutical; Manufacturing; Consumer Products; Diagnostic; Medical Device; Chemical; Health Care


Companies Profiled:
Allergan; Amgen; Bayer; Bristol-Myers Squibb; Eli Lilly and Company; Genentech; GlaxoSmithKline; Merck; Pfizer; Pharmacia; Procter & Gamble Pharma; Schering-Plough


Study Snapshot

Drawn from exclusive, one-on-one interviews with pharmaceutical and biotech executives, Best Practices in Speaker Training and Development: Driving Pharmaceutical Brand Growth profiles a class of companies that includes both large, powerful corporations and smaller, more nimble organizations. By studying these companies, your organization can gain a deeper understanding of how leading companies develop physicians into effective speakers.

After reading this report, you will understand how to design an effective, competitive training program, effectively identify potential speakers and optimize the use of speakers, and structure key stakeholder groups to have the greatest impact on speaker training.

Performance metrics enable executives to perform gap analyses and identify areas needing improvement. Metrics are an important complement to the qualitative best practices included in this study report. Best Practices, LLC analysts collected and analyzed the following key findings and metrics:

  • Training session length and frequency
  • Training session attendance
  • Speaker selection criteria
  • Speaker programs per product each year
  • Number of presentations per speaker
  • Speaker development staffing

This benchmarking study addresses five key dimensions of speaker training management, which include:
  • Training Program Design and Implementation
  • Speaker Identification and Utilization
  • Performance Measurement
  • Governance Structure
  • Resource Support

Key Findings

As the study will demonstrate, speaker training and development offers tremendous opportunities for drug companies to build long-term relationships with key opinion leaders (KOLs). The following key findings illustrate how companies optimize speaker management and development:
  • Design and implement formal speaker training programs to ensure consistency in speaker quality and message delivery. 92% of the interviewed executives reported that their companies currently employ formal programs to train and develop speakers. These formal training programs are designed and deployed to complement, not replace, other speaker development vehicles and activities such as informal coaching of speakers by field-based medical service liaisons, advisory boards and consultant meetings, media training, and online information updates. Working together, these channels serve as mutually reinforcing relationship-building tools that help form valuable bonds with influential KOLs and closely align them with the company and products.
  • Set clear criteria for speaker recruitment, training and utilization to align with brand objectives and strategies. Companies identify potential speakers for training by leveraging multiple channels and knowledge sources that include sales force, medical science liaisons, medical affairs, clinical development, marketing, and third-party vendors. To ensure consistent speaker selection, best-in-class companies have developed clear criteria seeking to balance strong technical knowledge and reputation with critical interpersonal skills.
  • Increase utilization of trained speakers by field reps through improved communication and information resource support. Companies that increase the usage of each trained speaker maximize investment and avoid wasting resources training physicians that never deliver presentations. Additionally, increased usage of all speakers raises the overall competency of the speaker pool. With each speaking engagement, physicians advance their presentation capabilities. By requiring reps to schedule under-utilized speakers for events, companies increase credibility, capitalize on training investments and develop a deep pool of skilled speakers.
Table of Contents

Executive Summary
· Project Overview
· Project Methodology
· Report Structure and Organization
· Key Findings

Speaker Training Program Design and Implementation
· Training Curriculum and Contents
· Logistics and Training Formats
· Creating Value

Balancing Standardization and Customization

Speaker Identification and Utilization
· Identifying Potential Speakers for Training
· Maximizing the Use of Trained Speakers

Performance Measurement
· Governance Structure
· Structure

Strategic Arrangements

Appendix
· PhRMA Code on Interactions with Healthcare Professionals
· Division of Drug Marketing, Advertising and Communications Frequently Asked Questions
· Compliance Guidance for Anti-Kickback Statute

List of Charts & Exhibits

Training Curriculum and Agenda
Presentation Skills Development
Training Sessions Per Year
Speaking Training Session Length
Program Size
Speakers Trained Per Specialty Brand
Integrated Speaker Development
Speaker Utilization
Governance Structure-Scenario 1
Governance Structure-Scenario 11
Organizational Alignment
Staffing Resources
Ensure Resource Support
Cost Per Attendee

RELATED RESEARCH